In May, the Food and Drug Administration issued much-anticipated guidance that could revolutionize the pricing of some of the most expensive drugs on the market in the U.S. and, possibly, globally.
Jun 4, 2019
0
0
After reviewing tens of millions of insurance claims for the country's 49 most popular brand-name prescription drugs, a team from Scripps Research Translational Institute found that net prices rose by a median of 76 percent ...
May 31, 2019
4
99
The World Health Organization's member states adopted on Tuesday a watered down resolution on improving drug price transparency that leading medical charity Doctors Without Borders (MSF) criticised as insufficient.
May 28, 2019
0
1
(HealthDay)—A generic version of the HIV preexposure prophylaxis (PrEP) drug Truvada will be available in the United States by September 2020, a year earlier than expected, according to Gilead Sciences.
May 10, 2019
0
1
Researchers from the University of Copenhagen have mapped the structure of an important channel in human muscle cells. The new insights about the chloride channel can contribute to greater understanding of muscle diseases ...
May 1, 2019
0
55
In American adolescents and young adults, death rates from drug poisoning, particularly from opioids, have sharply increased over the last 10 years, according to new research in the Journal of Studies on Alcohol and Drugs.
Apr 25, 2019
0
1
Withdrawal symptoms following the practice of discontinuation, or abruptly "coming off," of psychiatric drugs in randomized clinical trials may be mistaken for relapse and bolster the case for continued use of medication, ...
Apr 22, 2019
0
15
(HealthDay)—The first generic naloxone nasal spray to treat opioid overdose has received approval from the U.S. Food and Drug Administration.
Apr 19, 2019
0
1
Over the past thirteen years, many Australian women have used the drug mifepristone (RU486) to bring about a medical abortion.
Apr 1, 2019
0
1
Pharmaceutical companies Biogen and Eisai today (Thursday 21 March) announced they are to discontinue two phase III trials of the Alzheimer's drug aducanumab. The ENGAGE and EMERGE trials were designed to evaluate the efficacy ...
Mar 22, 2019
0
5
